Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009 (2009), Article ID 584916, 7 pages
http://dx.doi.org/10.1155/2009/584916
Research Article

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis

1Department of Nephrology, Lund University Hospital, Institute for Clinical Sciences, 221 85, Lund, Sweden
2Kidney Research Laboratory, BMC C14, 221 84, Lund, Sweden

Received 21 November 2008; Revised 31 March 2009; Accepted 11 May 2009

Academic Editor: Hidde Bult

Copyright © 2009 Sophie Ohlsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Jennette, A. S. Wilkman, and R. J. Falk, “Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis,” American Journal of Pathology, vol. 135, no. 5, pp. 921–930, 1989. View at Google Scholar
  2. E. Csernok, J. Ludemann, W. L. Gross, and D. F. Bainton, “Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis,” American Journal of Pathology, vol. 137, no. 5, pp. 1113–1120, 1990. View at Google Scholar
  3. M. Segelmark, K. Westman, and J. Wieslander, “How and why should we detect ANCA?” Clinical and Experimental Rheumatology, vol. 18, no. 5, pp. 629–635, 2000. View at Google Scholar
  4. M. C. Slot, J. W. C. Tervaert, C. F. M. Franssen, and C. A. Stegeman, “Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement,” Kidney International, vol. 63, no. 2, pp. 670–677, 2003. View at Publisher · View at Google Scholar
  5. F. W. K. Tam, J.-S. Sanders, A. George et al., “Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis,” Nephrology Dialysis Transplantation, vol. 19, no. 11, pp. 2761–2768, 2004. View at Publisher · View at Google Scholar
  6. J. Tencer, H. Thysell, K. Andersson, and A. Grubb, “Long-term stability of albumin, protein HC, immunoglobulin G, κ- and λ-chain-immunoreactivity, orosomucoid and α1-antitrypsin in urine stored at -20C,” Scandinavian Journal of Urology and Nephrology, vol. 31, no. 1, pp. 67–71, 1997. View at Google Scholar
  7. J. Tencer, O. Torffvjt, H. Thysell, B. Rippe, and A. Grubb, “Proteinuria selectivity index based upon α2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases: technical note,” Kidney International, vol. 54, no. 6, pp. 2098–2105, 1998. View at Publisher · View at Google Scholar
  8. J. W. Cohen Tervaert, F. J. van der Woude, A. S. Fauci et al., “Association between active Wegener's granulomatosis and anticytoplasmic antibodies,” Archives of Internal Medicine, vol. 149, no. 11, pp. 2461–2465, 1989. View at Google Scholar
  9. J. Calafat, R. Goldschmeding, P. L. Ringeling, H. Janssen, and C. E. van der Schoot, “In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes,” Blood, vol. 75, no. 1, pp. 242–250, 1990. View at Google Scholar
  10. P. Cockwell, C. J. Brooks, D. Adu, and C. O. S. Savage, “Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis,” Kidney International, vol. 55, no. 3, pp. 852–863, 1999. View at Publisher · View at Google Scholar
  11. I. L. Noronha, C. Kruger, K. Andrassy, E. Ritz, and R. Waldherr, “In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis,” Kidney International, vol. 43, no. 3, pp. 682–692, 1993. View at Google Scholar
  12. M. P. Rastaldi, F. Ferrario, S. Tunesi, L. Yang, and G. D'Amico, “Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1α expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis,” American Journal of Kidney Diseases, vol. 27, no. 1, pp. 48–57, 1996. View at Google Scholar
  13. S. Ohlsson, J. Wieslander, and M. Segelmark, “Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?” Mediators of Inflammation, vol. 13, no. 4, pp. 275–283, 2004. View at Publisher · View at Google Scholar
  14. C. F. M. Franssen, C. A. Stegeman, W. W. Oost-Kort et al., “Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 9, no. 10, pp. 1915–1923, 1998. View at Google Scholar
  15. H. A. Hauer, I. M. Bajema, H. C. Van Houwelingen et al., “Clinical nephrology-epidemiology-clinical trials: determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients,” Kidney International, vol. 62, no. 5, pp. 1732–1742, 2002. View at Publisher · View at Google Scholar
  16. B. A. Cohen and W. F. Clark, “Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy,” American Journal of Kidney Diseases, vol. 36, no. 5, pp. 914–924, 2000. View at Google Scholar
  17. M. A. Little, L. Nazar, and K. Farrington, “Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 356–364, 2004. View at Publisher · View at Google Scholar
  18. M. Segelmark, A.-N. Elzouki, J. Wieslander, and S. Eriksson, “The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis,” Kidney International, vol. 48, no. 3, pp. 844–850, 1995. View at Google Scholar
  19. S. Weidner, S. Geuss, S. Hafezi-Rachti, A. Wonka, and H. D. Rupprecht, “ANCA-associated vasculitis with renal involvement: an outcome analysis,” Nephrology Dialysis Transplantation, vol. 19, no. 6, pp. 1403–1411, 2004. View at Publisher · View at Google Scholar
  20. K. W. A. Westman, D. Selga, P.-E. Isberg, A. Bladström, and H. Olsson, “High proteinase 3-anti-neutrophil cytoplasmic antibody(ANCA)level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement,” Journal of the American Society of Nephrology, vol. 14, no. 11, pp. 2926–2933, 2003. View at Publisher · View at Google Scholar
  21. G. B. Appel, B. Gee, M. Kashgarian, and J. P. Hayslett, “Wegener's granulomatosis—clinical-pathologic correlations and long-term course,” American Journal of Kidney Diseases, vol. 1, no. 1, pp. 27–37, 1981. View at Google Scholar
  22. R. L. Heilman, K. P. Offord, K. E. Holley, and J. A. Velosa, “Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis,” American Journal of Kidney Diseases, vol. 9, no. 2, pp. 98–107, 1987. View at Google Scholar
  23. O. Bakoush, O. Torffvit, B. Rippe, and J. Tencer, “High proteinuria selectivity index based upon IgM is a strong predictor of poor renal survival in glomerular diseases,” Nephrology Dialysis Transplantation, vol. 16, no. 7, pp. 1357–1363, 2001. View at Google Scholar
  24. O. Bakoush, O. Torffvit, B. Rippe, and J. Tencer, “Renal function in proteinuric glomerular diseases correlates to the changes in urine IgM excretion but not to the changes in the degree of albuminuria,” Clinical Nephrology, vol. 59, no. 5, pp. 345–352, 2003. View at Google Scholar
  25. G. D'Amico and C. Bazzi, “Pathophysiology of proteinuria,” Kidney International, vol. 63, no. 3, pp. 809–825, 2003. View at Publisher · View at Google Scholar
  26. O. Bakoush, M. Segelmark, O. Torffvit, S. Ohlsson, and J. Tencer, “Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis,” Nephrology Dialysis Transplantation, vol. 21, no. 5, pp. 1263–1269, 2006. View at Publisher · View at Google Scholar
  27. L. Boring, J. Gosling, S. W. Chensue et al., “Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice,” The Journal of Clinical Investigation, vol. 100, no. 10, pp. 2552–2561, 1997. View at Google Scholar
  28. B. H. Rovin, M. Rumancik, L. Tan, and J. Dickerson, “Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis,” Laboratory Investigation, vol. 71, no. 4, pp. 536–542, 1994. View at Google Scholar
  29. T. Wada, K. Furuichi, N. Sakai et al., “Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy,” Kidney International, vol. 58, no. 4, pp. 1492–1499, 2000. View at Publisher · View at Google Scholar
  30. G. H. Tesch, “MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy,” American Journal of Physiology, vol. 294, no. 4, pp. F697–F701, 2008. View at Publisher · View at Google Scholar
  31. B. Rovin, “Urinary MCP-1 is a sensitive and specific biomarker of renal systemic lupus erythematosus,” Journal of the American Society of Nephrology, 2005. View at Google Scholar
  32. A. R. Exley, P. A. Bacon, R. A. Luqmani, G. D. Kitas, D. M. Carruthers, and R. Moots, “Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI),” British Journal of Rheumatology, vol. 37, no. 1, pp. 57–63, 1998. View at Google Scholar
  33. K. W. A. Westman, D. Selga, P. Bygren et al., “Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody: technical note,” Kidney International, vol. 53, no. 5, pp. 1230–1236, 1998. View at Publisher · View at Google Scholar
  34. A. Wiik, N. Rasmussen, and J. Wieslander, “Methods to detect autoantibodies to neutrophilic granulocytes,” Manual of Biological Markers of Disease, vol. A9, pp. 1–14, 1993. View at Google Scholar
  35. C. M. Lloyd, A. W. Minto, M. E. Dorf et al., “RANTES and monocyte chemoattract protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis,” The Journal of Experimental Medicine, vol. 185, p. 10, 1997. View at Google Scholar
  36. T. Wada, H. Yokoyama, K. Furuichi et al., “Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1),” FASEB Journal, vol. 10, no. 12, pp. 1418–1425, 1996. View at Google Scholar
  37. Y. Li, M. Tucci, S. Narain et al., “Urinary biomarkers in lupus nephritis,” Autoimmunity Reviews, vol. 5, no. 6, pp. 383–388, 2006. View at Publisher · View at Google Scholar